Fig. 9From: Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood–brain barrier modelSchematic of the delivery of Afa/LPN-FD7 and Afa/LPN-CCD across the BBB model of bEnd.3 cells via paracellular and transcellular pathways to transport AfaBack to article page